Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
Atherosclerosis
|
March 11, 2021
TRS2P and LDL-C alone or in combination for predicting absolute benefits from additional LDL-C lowering: Analysis from the TNT trial
Toshiyuki Nishikido, Rana Fayyad, Shari Melamed, et al.
The American Journal of Psychiatry
|
June 3, 2005
Quality-of-life impairment in depressive and anxiety disorders
Mark Hyman Rapaport, Cathryn Clary, Rana Fayyad, et al.
Journal of Affective Disorders
|
March 23, 2005
Pretreatment pattern of symptom expression in premenstrual dysphoric disorder
Teri Pearlstein, Kimberly A Yonkers, Rana Fayyad, et al.
Journal of Affective Disorders
|
March 23, 2005
Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase
Kimberly A Yonkers, Teri Pearlstein, Rana Fayyad, et al.
Current Medical Research and Opinion
|
December 29, 2015
Effect of metabolic syndrome and thyroid hormone on efficacy of desvenlafaxine 50 and 100 mg/d in major depressive disorder
Roger S McIntyre, Rana Fayyad, Joan A Mackell, et al.
Pain and Therapy
|
September 19, 2017
Comparing the Safety and Efficacy of Celecoxib for the Treatment of Osteoarthritis in Asian and non-Asian Populations: An Analysis of Data from Two Randomized, Double-blind, Placebo-controlled, Active-comparator Trials
Andri Lubis, Wei Wang, Graça Lima, et al.
Professional Case Management
|
February 6, 2014
Real-world disparities between patient- and clinician-reported outcomes: results from a disease-specific program in depression and anxiety
Shannon Lubaczewski, Jason Shepherd, Rana Fayyad, et al.
The Journal of Sexual Medicine
|
August 22, 2012
An evaluation of sexual functioning in employed outpatients with major depressive disorder treated with desvenlafaxine 50 mg or placebo
Anita H Clayton, Sujana Reddy, Kristen Focht, et al.
Clinical Drug Investigation
|
June 3, 2017
Effectiveness of Lipid-Lowering Statin Therapy in Patients With and Without Psoriasis
William C Ports, Rana Fayyad, David A DeMicco, et al.
Journal of Traumatic Stress
|
February 26, 2005
Clinical correlates of poor sleep quality in posttraumatic stress disorder
Anne Germain, Daniel J Buysse, M Kathy Shear, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
Atherosclerosis
|
March 11, 2021
TRS2P and LDL-C alone or in combination for predicting absolute benefits from additional LDL-C lowering: Analysis from the TNT trial
Toshiyuki Nishikido, Rana Fayyad, Shari Melamed, et al.
The American Journal of Psychiatry
|
June 3, 2005
Quality-of-life impairment in depressive and anxiety disorders
Mark Hyman Rapaport, Cathryn Clary, Rana Fayyad, et al.
Journal of Affective Disorders
|
March 23, 2005
Pretreatment pattern of symptom expression in premenstrual dysphoric disorder
Teri Pearlstein, Kimberly A Yonkers, Rana Fayyad, et al.
Journal of Affective Disorders
|
March 23, 2005
Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase
Kimberly A Yonkers, Teri Pearlstein, Rana Fayyad, et al.
Current Medical Research and Opinion
|
December 29, 2015
Effect of metabolic syndrome and thyroid hormone on efficacy of desvenlafaxine 50 and 100 mg/d in major depressive disorder
Roger S McIntyre, Rana Fayyad, Joan A Mackell, et al.
Pain and Therapy
|
September 19, 2017
Comparing the Safety and Efficacy of Celecoxib for the Treatment of Osteoarthritis in Asian and non-Asian Populations: An Analysis of Data from Two Randomized, Double-blind, Placebo-controlled, Active-comparator Trials
Andri Lubis, Wei Wang, Graça Lima, et al.
Professional Case Management
|
February 6, 2014
Real-world disparities between patient- and clinician-reported outcomes: results from a disease-specific program in depression and anxiety
Shannon Lubaczewski, Jason Shepherd, Rana Fayyad, et al.
The Journal of Sexual Medicine
|
August 22, 2012
An evaluation of sexual functioning in employed outpatients with major depressive disorder treated with desvenlafaxine 50 mg or placebo
Anita H Clayton, Sujana Reddy, Kristen Focht, et al.
Clinical Drug Investigation
|
June 3, 2017
Effectiveness of Lipid-Lowering Statin Therapy in Patients With and Without Psoriasis
William C Ports, Rana Fayyad, David A DeMicco, et al.
Journal of Traumatic Stress
|
February 26, 2005
Clinical correlates of poor sleep quality in posttraumatic stress disorder
Anne Germain, Daniel J Buysse, M Kathy Shear, et al.
Page
of 6